Haematologica (Sep 2007)

Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome

  • Marie Robin,
  • Stéphanie Marque-Juillet,
  • Catherine Scieux,
  • Régis Peffault de Latour,
  • Christèle Ferry,
  • Vanderson Rocha,
  • Jean-Michel Molina,
  • Anne Bergeron,
  • Agnès Devergie,
  • Eliane Gluckman,
  • Patricia Ribaud,
  • Gérard Socié

DOI
https://doi.org/10.3324/haematol.11279
Journal volume & issue
Vol. 92, no. 9

Abstract

Read online

We analyzed the factors and outcome of patients with disseminated adenovirus infection (dAdV) after allogeneic hematopoeitic stem cell transplantation (HSCT). Thirty patients with dAdV were identified among 620 allogeneic HSCT recipients. Primary diseases were leukemia (n=17), Fanconi anemia (n=12) or others (n=1). Source of stem cells was unrelated in 28 and related in 2 patients. The graft consisted of peripheral blood (n=3), bone marrow (n=12) and unrelated cord-blood (UCB, n=15). Risk factors for dAdV in unrelated HSCT recipients were previous Fanconi disease (p=0.03) and GVHD (p=0.02) in children, and cord blood source of stem cells (p=0.029) and GVHD (0.024) in adults.